Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110229796B details enzymatic synthesis for high-purity duloxetine intermediates. Offers cost reduction and supply chain reliability for pharma manufacturing.
Patent CN110951799A reveals a novel whole-cell enzymatic route for high-purity (2S,3R)-p-methylsulfonylphenylserine, offering significant cost reduction and scalable green manufacturing for antibiotic intermediates.
Patent CN111747827A reveals efficient oxidative coupling for biphenyl pyrogallol intermediates. Enables cost reduction in fine chemical manufacturing and scalable ligand synthesis.
Discover the patented CN101270038B method for synthesizing high-purity 4,4'-dihydroxybenzophenone using recycled carbon tetrachloride and solid superacid catalysts for cost-effective manufacturing.
Patent CN103492351B details efficient dehydrogenation oxidation for carbonyl compounds. Enables cost reduction in fine chemical manufacturing and reliable supply chain.
Novel IBX oxidation method for beta-carotene production. Achieves higher yields and purity with milder conditions. Ideal for food and feed additive manufacturing.
Novel patent CN101270038B details a green synthesis of 4,4'-dihydroxybenzophenone using carbon tetrachloride and solid superacids, offering cost reduction and environmental compliance for pharmaceutical intermediates.
Novel zinc-mediated reduction route for Roxadustat intermediates. High purity, scalable, and cost-effective manufacturing solution for pharmaceutical supply chains.
Discover advanced biphenyl tridentate phosphite ligands from patent CN111848683A. Enhance hydroformylation efficiency and reduce costs in plasticizer intermediate manufacturing.
Patent CN115109759A reveals engineered carbonyl reductases achieving 600g/g S/C ratio. Discover cost-effective biocatalytic routes for chiral alcohol production.
Patent CN113234696B details a novel in vitro enzymatic route for crocetin from zeaxanthin, offering superior purity and scalable production for fine chemical manufacturing.
Patent CN118374468B reveals mutant transaminase for high yield chiral amine intermediate production with improved stereoselectivity.
Patent CN105002234B reveals enzymatic cAMP synthesis. Offers high purity, cost reduction, and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN106978368B details a novel nitrilase biocatalysis route for L-glufosinate precursors, offering high optical purity and reduced environmental impact for agrochemical manufacturing.
Patent CN106191150A details a co-immobilized enzymatic method for D-alanine. Achieves >98% purity with continuous 55-day operation, offering significant supply chain stability and cost reduction.
Novel Ni-catalyzed photochemical synthesis offers cost reduction and high enantioselectivity for pharmaceutical intermediates manufacturing.
Novel ionic liquid method for cyclopentanone ensures high yield and purity. Ideal for pharma and agrochemical supply chains seeking cost reduction.
Patent CN109943542A reveals enhanced ADH for Atazanavir. Lower cost, green synthesis, high purity pharmaceutical intermediates for global supply chains.
Patent CN110922427A reveals TMSOTf-catalyzed route for sterically hindered phosphonites. Green, solvent-free process offers cost reduction in pharma intermediate manufacturing.
Patent CN109576234B reveals a highly active V77A mutant enzyme enabling efficient biosynthesis of hydroxylated amino acids, offering significant cost reduction in API manufacturing and reliable supply chain solutions.